Anan Tawil
Vascular Surgery · Corvallis, ORNPI 1538450135
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,765 of the $7,892 with a category attached, or 60.4%. 28 manufacturers reported payments, led by Medtronic at 40.5% of the total.
Across 80 payments — averaging $98.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Cordis US CORP.$1K
- W. L. Gore & Associates, Inc.$691
- Globus Medical$660
- Stryker$648
- Endologix LLC$532
- plus $916 from 22 others
What the payments were for
- Travel & lodging$4,76560%
- Food & beverage$3,12740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 22 | $3,200 |
| Cordis US CORP. | 7 | $1,245 |
| W. L. Gore & Associates, Inc. | 6 | $691 |
| Globus Medical(2 entities) | 2 | $660 |
| Stryker | 5 | $648 |
| Endologix LLC | 2 | $532 |
| Cook Medical LLC | 5 | $180 |
| Penumbra, Inc. | 2 | $127 |
| E.r. Squibb & Sons, L.L.C. | 3 | $74 |
| Impulse Dynamics (USA) Inc. | 1 | $58 |
| Bard Peripheral Vascular, Inc. | 4 | $49 |
| Shockwave Medical, Inc | 2 | $46 |
| Silk Road Medical, Inc. | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $36 |
| Innovation Technologies Inc | 1 | $30 |
| Tactile Systems Technology Inc | 1 | $28 |
| Pfizer | 1 | $28 |
| Bayer | 2 | $26 |
| Johnson & Johnson | 1 | $24 |
| Cvrx, Inc. | 1 | $24 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $24 |
| Inari Medical, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,892 in reported general payments places this provider in the 65th percentile of 56 vascular surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $12,274 |
| XareltoRivaroxaban | 11 | $9,255 |
| ClopidogrelClopidogrel Bisulfate | 327 | $2,885 |
| Cilostazol | 56 | $1,568 |
| Pentoxifylline | 30 | $709 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $451 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $143 |
| Amlodipine Besylate | 14 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $28 | $12,27417 claims |
| Johnson & JohnsonXarelto | $24 | $9,25511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 56 vascular surgery providers in Oregon.
Other vascular surgery in Corvallis
- Jeffrey CrawfordCorvallis$46K
- Aditi MadabhushiCorvallis$4K
- Brant UlleryWilsonville$816K
- Mark MoraschSpringfield$127K
- Cherrie AbrahamPortland$80K
- Wayne NelsonBend$69K
- Paul LongBend$62K
- Craig SeidmanSpringfield$20K
- John DusselWilsonville$20K
- Erica MitchellPortland$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.